Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-17-012835
Filing Date
2017-10-02
Accepted
2017-10-02 16:07:48
Documents
2
Period of Report
2017-09-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1729
2 POWER OF ATTORNEY ex24koven.txt EX-24 4256
  Complete submission text file 0001179110-17-012835.txt   7375
Mailing Address 3 COLUMBUS CIRCLE, SUITE 1710 C/O ARALEZ PHARMACEUTICALS INC. NEW YORK NY 10019
Business Address
KOVEN ANDREW I (Reporting) CIK: 0001258673 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38150 | Film No.: 171114597

Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Issuer) CIK: 0001479419 (see all company filings)

EIN.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations